Concepedia

Formulation and evaluation of metoclopramide solid lipid nanoparticles for rectal suppository

Radwa A Mohamed, Haidy Abass, Mohamed A. Attia, Ola A. Heikal

Journal of Pharmacy and Pharmacology · 2013 · 41 citations · 33 references

Open access

Abstract

MCP-SLN suppositories (formula F) can reverse decrease in %GE because of emesis with sustained release effect. So it succeeded to be an alternative to MCP suppositories with no multiple dosing.

References

33

Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism

A. zur Mühlen, C. Schwarz, W. Mehnert · European Journal of Pharmaceutics and Biopharmaceutics · 1998 · 927 citations

Nanoparticles, Nanomedicine, Engineering +9

Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method

Yi Yan Yang · Biomaterials · 2001 · 700 citations

Biopolymer Gel, Vitro Release Profiles, Microemulsion +6

Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization

C. Schwarz, W. Mehnert, J.S. Lucks et al. · Journal of Controlled Release · 1994 · 564 citations

Nanoparticles, Nanomedicine, Engineering +6

Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles

Vobalaboina Venkateswarlu, K Manjunath · Journal of Controlled Release · 2004 · 552 citations

Nanoparticles, Lipid Preparation, Engineering +8

Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties

Volkhard Jenning, Monika Schäfer‐Korting, Sven Gohla · Journal of Controlled Release · 2000 · 539 citations

Nanoparticles, Engineering, Topical Use +7